Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Meriden Ave Ste 1a
Southington, CT 06489Phone+1 860-621-9316
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
- NYU Grossman School of MedicineResidency, Internal Medicine, 2004 - 2007
- New York University School of MedicineClass of 2004
Certifications & Licensure
- CT State Medical License 2011 - 2025
- NY State Medical License 2006 - 2011
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Publications & Presentations
PubMed
- 59 citationsOverall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.Justin Jee, Emily S Lebow, Randy Yeh, Jeeban P Das, Azadeh Namakydoust
Nature Medicine. 2022-11-01 - 35 citationsOblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trialPatrick A. Ott, Jason L. Chang, Kathleen M. Madden, Rajni Kannan, Caroline Muren
Cancer Chemotherapy and Pharmacology. 2013-01-01 - 13 citationsPhase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.Patrick A. Ott, Jason L. Chang, Ruth Oratz, Amanda Jones, K. Farrell
Chemotherapy. 2009-05-19
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: